Cognitive And Behavioural Challenges In Children With Lysosomal Storage Diseases
Published on: July 24, 2025
Cognitive And Behavioural Challenges In Children With Lysosomal Storage Diseases
Article author photo

Megan Tan

Bachelor of Medical Innovation & Enterprise (2026)

Article reviewer photo

Elizabeth Olanipekun

Bachelor of science in Biomedical Science

What are lysosomal storage diseases (LSDs)?

Lysosomal storage diseases (LSDs) are a group of more than 50 rare inherited disorders that affect the body’s ability to break down and recycle certain substances inside cells.1 The ‘recycling centre’ of our cells is some small structures called lysosomes, which contain special proteins (enzymes) that help break down complex molecules such as sugars, fats, and proteins into smaller components that the cell can further use, or need to get rid of.1,2

LSDs are caused by a genetic mutation, which is a faulty gene that causes one of these crucial enzymes to be missing or not functioning properly. As a result, the substances that should be broken down start to build up inside the lysosomes. Over time, this accumulation of components can damage the cells and tissues all throughout the body, including the brain, liver, heart, muscles and bones. The type of mutation influences severity and onset – the complete loss of activity of an enzyme is often lethal, while partially reduced enzyme activity is associated with milder symptoms.1,2

There are over 70 types of LSDs, and each one of them affects the body differently depending on which enzyme is missing and where the buildup occurs. Some types mostly affect the bone, heart and liver, while other types have a big impact on the brain and on the nervous system. When the brain is affected, children may have problems with thinking, learning, memory and behaviour. This is why some LSDs are linked with cognitive and developmental challenges.2 

While LSDs are rare (1 in 7500), early diagnosis in support can make a big difference. Many families do not realise any abnormalities or problems at the beginning. In some cases, it takes a variable time after birth before the clinical manifestations start to appear. With the varying age of onset and clinical outcomes, LSDs may be identified with difficulty or be mistaken for other diseases.2,3

It is important to raise awareness and help people understand these diseases and how they affect children’s lives. 

What are the challenges for affected children?

Lysosomal storage diseases present symptoms that can appear very early in life, sometimes even before birth. Many types of LSDs are first noticed when a child fails to reach developmental milestones, such as sitting, talking, or walking at the expected ages, or when a child starts losing skills they have already learnt.2

Children are especially vulnerable because their bodies and brains are still developing. When the body’s cells and tissues are damaged by the buildup of substances, it can have a major impact on growth, learning skills and daily functioning. In some LSDs, symptoms progress rapidly, leading to significant health challenges. LSDs may present a non-congenital onset and a progressive course, ultimately leading to premature death if not treated.3

Early diagnosis and intervention are crucial for children with LSDs, as some treatments can help slow the progression of the disease or manage symptoms, improving the quality of life. Raising awareness of the possible symptoms children may experience helps their families, caregivers, and healthcare providers recognise early signs and provide the best possible care and support.2,3

Understanding the brain and behaviour

How LSDs affect the brain 

In LSDs, the body’s inability to break down certain substances causes these materials to accumulate inside cells – the brain cells can also be affected, increasing the severity of the disorder. Over time, this buildup can damage or even destroy neurons (nerve cells) – responsible for sending messages throughout the brain and body. As more material accumulates, the brain’s normal structure and function are disrupted, especially in the areas which are responsible for critical thinking, memory, movement, coordination, and behaviour.4 

Why do these problems happen?

The brain relies on a delicate balance of chemicals and well-functioning cells to process information, control movements, and regulate emotions. In children with LSDs, the buildup of undigested substances inside neurons interferes with these processes. This can slow down or block the communication between brain cells, causing damage and, in some cases, leading to the death of brain cells, which can cause a range of neurological symptoms.4

As a result, children may experience difficulties with learning skills, remembering information, paying attention, or controlling their behaviour. These problems may worsen over time as more brain cells are affected.4 

Which type of LSD affects the brain most?

Not all LSDs affect the brain, but some are particularly known for causing severe and early neurological involvement. These include: 1,4

Symptoms of LSDs may look like other neurological or developmental disorders, which may sometimes be missed or misdiagnosed. Thus, understanding the effects of LSDs on the brain is so important for early intervention.1

Common cognitive challenges in children with LSDs

Children with LSDs often face a range of cognitive challenges that can affect their learning, development, and daily life. These challenges can vary from mild to severe and often progress over time. Below are some of the most common issues: 4

Learning problems and developmental delays

Children with LSDs may take longer to reach developmental milestones, such as walking, talking, or learning to read. They may struggle to stay focused on a task, remember new information, or recall things they have learnt before. This can make it hard to keep up in school or learn new skills.4,5

Language and speech difficulties

Some children may have trouble recognising words or struggle to understand what others are saying. They might speak less than expected for their age, struggle to find the right words, or have difficulty forming sentences. Some children may understand what’s being said but have trouble expressing themselves clearly.4

Regression (Losing skills already learnt)

A particularly challenging aspect of some LSDs is that children may lose abilities they previously had. This is known as “regression” and may include the loss of speech – a child who could speak in sentences may begin to lose words or stop talking altogether. They may also lose their motor skills, like walking, running, or hand coordination. As the disease progresses, children need more help with daily activities like eating, getting dressed, or using the bathroom.4

Children with LSDs may struggle with learning, experience delays in reaching milestones, and lose skills they have already mastered. Early recognition and support are crucial to help them reach their fullest potential.4

Common behavioural challenges 

Children with lysosomal storage diseases (LSDs) not only face cognitive difficulties, but they also often experience a range of behavioural challenges, such as:5

These behaviours can be confusing or distressing for families, teachers, and caregivers. However, understanding them is the first step toward providing support and early intervention. 

How these challenges affect daily life

Impact on school and learning

Cognitive and behavioural challenges from LSDs can make school especially difficult. Children may: 5

  • Struggle with reading, writing, and math
  • Have trouble paying attention or remembering instructions
  • Find it hard to keep up with peers
  • Experience difficulties making friends or participating in group activities 

Impact on family and relationships

The effects of LSDs may impact the whole family. Daily life often requires extra planning and flexibility. Whether it’s getting ready for school, attending medical appointments, or managing behavioural episodes, routines can become more complex. Families may: 5

  • Experience increased stress and worry about their child’s future
  • Spend extra time helping with school work or daily care
  • Need to adjust routines or seek outside help 
  • Feel isolated or overwhelmed by the demands of caregiving

Caregivers may experience feelings of guilt, sadness, or burnout as they try to balance caregiving with other responsibilities. The emotional, physical, and financial toll can be overwhelming for caregivers. Support from professionals, peer groups, and community resources can make a real difference.5,6

Diagnosis and monitoring

Recognising symptoms early is crucial. The sooner a child is diagnosed, the sooner they can receive support and therapies that may slow the progression of symptoms and improve quality of life. Doctors and specialists use a variety of tools to assess how a child is thinking, learning, and behaving. Some common methods include:2,3,7

  • Physical examination: Findings such as facial dysmorphology, organomegaly (enlarged liver and spleen), neurological symptoms
  • Laboratory testing: Blood, urine, or tissue samples are tested to measure the activity of specific lysosomal enzymes. Low or absent enzyme activity can indicate an LSD
  • Genetic testing: DNA analysis can confirm the diagnosis by identifying mutations

Regular monitoring is critical for children with LSD, as the conditions are progressive and symptoms may evolve over time. Regular monitoring allows healthcare providers to detect changes in symptoms, cognition and adjust learning or therapy plans as needed. 

Treatment and support options

While there is currently no cure for most LSDs, there are many ways to help children manage the cognitive and behavioural symptoms that often come with these conditions. With the right combination of therapies, educational tools, and emotional support, families can better navigate the challenges and improve the child’s quality of life.1,4,8

Therapies that may help include:1,4,5

In some cases, doctors may recommend medications to manage specific symptoms such as mood or anxiety disorders, sleep disturbances, and hyperactivity.5 

Hope for the future

There is growing hope for children with lysosomal storage diseases (LSDs) thanks to exciting advances in the treatment. New therapies, such as gene therapy, are being developed and tested to correct the underlying genetic problem by replacing the missing or faulty gene.2,4,8 This offers the potential to slow down disease progression and improve symptoms. 

Continued research is crucial. Scientists and doctors are working hard to discover better treatments, understand LSDs more fully, and find ways to improve the quality of life for children affected by LSDs and their families. Progress may take time, but each discovery brings us closer to more effective therapies, and maybe a cure one day.4 

Summary

Children with LSDs face significant cognitive and behavioural challenges that can affect every part of their lives. While these conditions are complex and often progressive, early diagnosis, regular monitoring, and a combination of medical and supportive therapies can make a big difference.

With the right support system, children with LSDs can continue to learn, grow, and experience moments of joy. Empowered with knowledge and compassion, caregivers and families can be strong advocates for their child’s future.

References

  1. Sun A. Lysosomal storage disease overview. Ann Transl Med [Internet]. 2018 [cited 2025 Jun 20]; 6(24):476. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6331358/.
  2. Rajkumar V, Dumpa V. Lysosomal Storage Disease. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 [cited 2025 Jul 23]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK563270/
  3. Alkhzouz C, Miclea D, Bucerzan S, Lazea C, Nascu I, Sido PG. Early clinical signs in lysosomal diseases. Med Pharm Rep [Internet]. 2021 [cited 2025 Jun 20]; 94 (Suppl No 1):S43–6. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8411815/.
  4. Elendu C, Babawale EA, Babarinde FO, Babatunde OD, Chukwu C, Chiegboka SF, et al. Neurological manifestations of lysosomal storage diseases. Ann Med Surg (Lond) [Internet]. 2024 [cited 2025 Jun 20]; 86(11):6619–35. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11543150/.
  5. Escolar ML, Jones SA, Shapiro EG, Horovitz DDG, Lampe C, Amartino H. Practical management of behavioral problems in mucopolysaccharidoses disorders. Molecular Genetics and Metabolism [Internet]. 2017 [cited 2025 Jun 20]; 122:35–40. Available from: https://www.sciencedirect.com/science/article/pii/S1096719217303955.
  6. Hassall S, Smith DM, Rust S, Wittkowski A. A systematic review and integrative sequential explanatory narrative synthesis: The psychosocial impact of parenting a child with a lysosomal storage disorder. J Inherit Metab Dis [Internet]. 2022 [cited 2025 Jun 20]; 45(3):406–16. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9305282/.
  7. Mokhtariye A, Hagh-Nazari L, Varasteh A-R, Keyfi F. Diagnostic methods for Lysosomal Storage Disease. Rep Biochem Mol Biol [Internet]. 2019 [cited 2025 Jun 20]; 7(2):119–28. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6374068/.
  8. Fernández-Pereira C, San Millán-Tejado B, Gallardo-Gómez M, Pérez-Márquez T, Alves-Villar M, Melcón-Crespo C, et al. Therapeutic Approaches in Lysosomal Storage Diseases. Biomolecules [Internet]. 2021 [cited 2025 Jun 20]; 11(12):1775. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8698519/.
Share

Megan Tan

Bachelor of Medical Innovation & Enterprise (2026)
Diploma - Biomedical Science (2023)

arrow-right